Sebastian Aguiar: “The Geroscience Revolution.”

Sebastian Aguiar, geroscientist and Venture Fellow at Apollo Ventures, delivers the Lord Florey Lecture at Lincoln College, Oxford in November 2018. He was a Clarendon Scholar at Lincoln College, Oxford for his DPhil (PhD) on the biochemistry of aging. Aguiar presents topics such as the Silver Tsunami, promising industry developments, and exciting examples of healthspan…

How many mutations before stem cells go kaput?

Imagine that today is your first day at a brand new job, and your new boss slaps an enormous booklet on your desk, then walks off without a word. The front of the booklet reads “HOW TO DO YOUR JOB”, and underneath in smaller print is the word accountant, and underneath that is the number…

Space aging

People have been talking about terraforming and colonizing Mars since the beginning of space travel, and in the past few years that ambition seems to have gone mainstream. But if we want to conquer the “final frontier” of space, we must first confront that other final frontier. Because, as it turns out, the problem with…

An ounce of prevention | Interview with Dr. Michael Ristow (part iii)

For the most part, we know how to mitigate the chronic diseases that plague people in their older years–eat healthily from early on, and get plenty of exercise. But this knowledge hasn’t translated into better health for society at large, and medical systems all around the world are straining increasingly under the weight of aging…

Using neurodegeneration to fight cancer safely and effectively

The researchers bound the kind of siRNA found in Huntington’s disease with a complementary strand from another degenerative disorder, myotonic dystrophy, to create a hybrid duplex, then put this inside nanoparticles that were quickly gobbled up by cancer cells in culture. All varieties of cancer tested–ovarian, lung, liver, melanoma, and several more–stopped growing within a…

The chaotic inner life of cancer

(Continued from part I) Most people who’ve meet cancer on the battlefield of treatment, doctors or patients, come away with the impression of a robust and formidable foe that can only be defeated with the most terrible weapons. But this impression is somewhat misleading. The cancers that come to our attention are selected for being…

What’s new in media and industry: Who’s who in longevity, and more

Here’s our handpicked selection of the best interviews, blog posts, popular articles, and breaking biotech news of the last two weeks: Want a systematic overview of every organization chipping away at human aging right now? Then you’ll love this nearly 800-page report from the Biogerontology Research Foundation. Put it in your queue for bedtime reading….

Glucosamine: The new metformin? | Interview with Dr. Michael Ristow (part ii)

Last week when we heard from Dr. Ristow, he turned the outdated notion of the “free radical theory of aging” on its head, and demonstrated that antioxidants like vitamin A and vitamin C aren’t all they’re cracked up to be. But if those supplements can’t help us, what can? Perhaps, says Ristow, the answer can…

Cancer’s little helper

A menacing shadow looms large over the body. Lessons we’ve learned from the eternal struggle of organism against cell are etched into the farthest corners of the genome, patches on top of patches, shoring up our weaknesses for the next time the conflict erupts. And yet, even with a standing army dedicated to repairing DNA,…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD